Equal Access to Therapeutics Act

Summary

Equal Access to Therapeutics Act This bill prohibits using race or ethnicity as a factor in decisions about an individual's access to COVID-19 treatments (e.g., monoclonal antibody therapies). Specifically, the Department of Health and Human Services (HHS) may not adopt any policy or guidance that allows race or ethnicity to be factored into such decisions. Furthermore, the Secretary of HHS shall be personally liable for the death of any individual who is denied access to COVID-19 treatments pursuant to a prohibited policy or guidance. The bill also prohibits hospitals or other health care providers that have policies restricting access to COVID-19 treatments based on race or ethnicity from receiving federal funds.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 7 February 2022

   Introduced

   Referred to the House Committee on Energy and Commerce.

   Source: IntroReferral

2. 7 February 2022

   Introduced

   Introduced in House

   Source: IntroReferral

3. 7 February 2022

   Introduced

   Introduced in House

   Source: IntroReferral

4. 8 February 2022

   Referred

   Referred to the Subcommittee on Health.

   Source: Committee

Votes

No vote records are attached yet.

Versions

• Introduced in House · 7 February 2022 · Download file

Documents

3 official files

• Introduced in House (text)

  Introduced in House · EN · 7 February 2022

  ViewDownloadOpen at official source

• Introduced in House (PDF)

  Introduced in House · EN · 7 February 2022

  ViewDownloadOpen at official source

  Leesvertaling

  Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

  Vertaal naarNL · DutchDE · GermanFR · FrenchES · SpanishIT · ItalianPL · PolishPT · PortugueseSV · SwedishDA · DanishFI · FinnishEL · GreekCS · CzechHU · HungarianRO · RomanianBG · BulgarianHR · CroatianSK · SlovakSL · SlovenianLT · LithuanianLV · LatvianET · EstonianGA · IrishMT · Maltese

  Vertaal document

  Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

• Introduced in House

  summary · EN · 7 February 2022

  Open at official source

  Leesvertaling

  Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

  Vertaal naarNL · DutchDE · GermanFR · FrenchES · SpanishIT · ItalianPL · PolishPT · PortugueseSV · SwedishDA · DanishFI · FinnishEL · GreekCS · CzechHU · HungarianRO · RomanianBG · BulgarianHR · CroatianSK · SlovakSL · SlovenianLT · LithuanianLV · LatvianET · EstonianGA · IrishMT · Maltese

  Vertaal document

  Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

• Rep. Davis, Rodney [R-IL-13] · R · Sponsor
• Rep. Malliotakis, Nicole [R-NY-11] · R · Sponsor
• Rep. Garbarino, Andrew R. [R-NY-2] · R · Sponsor
• Rep. Graves, Sam [R-MO-6] · R · Sponsor
• Rep. Van Duyne, Beth [R-TX-24] · R · Sponsor
• Rep. Feenstra, Randy [R-IA-4] · R · Sponsor
• Rep. Lamborn, Doug [R-CO-5] · R · Sponsor
• Rep. Cammack, Kat [R-FL-3] · R · Sponsor
• Rep. Bost, Mike [R-IL-12] · R · Sponsor
• Rep. Tenney, Claudia [R-NY-24] · R · Sponsor
• Rep. Gibbs, Bob [R-OH-7] · R · Cosponsor
• Rep. Fortenberry, Jeff [R-NE-1] · R · Cosponsor
• Rep. McKinley, David B. [R-WV-1] · R · Cosponsor
• Rep. Van Drew, Jefferson [R-NJ-2] · R · Cosponsor
• Rep. Grothman, Glenn [R-WI-6] · R · Cosponsor
• Chris Jacobs · R · Cosponsor
• Rep. Smith, Jason [R-MO-8] · R · Cosponsor
• · hsif00 · Standing

Related records

No cross-record relationships stored yet.